Bedoukian   RussellIPM   RussellIPM   Piezoelectric Micro-Sprayer


Home
Animal Taxa
Plant Taxa
Semiochemicals
Floral Compounds
Semiochemical Detail
Semiochemicals & Taxa
Synthesis
Control
Invasive spp.
References

Abstract

Guide

Alphascents
Pherobio
InsectScience
E-Econex
Counterpart-Semiochemicals
Print
Email to a Friend
Kindly Donate for The Pherobase

« Previous AbstractChanges in electrophysiological activity in the accessory olfactory bulb and medial amygdala associated with mate recognition in mice    Next AbstractDiscrimination of COPD and lung cancer from controls through breath analysis using a self-developed e-nose »

Acta Bioeng Biomech


Title:Design and development of an e-nose system for the diagnosis of pulmonary diseases
Author(s):Binson VA; Subramoniam M;
Address:"Department of Electronics Engineering, Sathyabama Institute of Science & Technology, Chennai, India"
Journal Title:Acta Bioeng Biomech
Year:2021
Volume:23
Issue:1
Page Number:35 - 44
DOI:
ISSN/ISBN:1509-409X (Print) 1509-409X (Linking)
Abstract:"PURPOSE: The aim of this paper was to discuss the design and development of an innovative e-nose system which can detect respiratory ailments by detecting the Volatile Organic Compounds (VOCs) in the expelled breath. In addition to nitrogen, oxygen, and carbon dioxide, the expelled breath contains several VOCs, some of which are indicative of lung-related conditions and can differentiate healthy controls from people affected with pulmonary diseases. METHODS: This work detailed the sensor selection process, the assembly of the sensors into a sensor array, the design and implementation of the circuit, sampling methods, and an algorithm for data analysis. The clinical feasibility of the system was checked in 27 lung cancer patients, 22 chronic obstructive pulmonary disease (COPD) patients, and 39 healthy controls including smokers and non-smokers. RESULTS: The classification model developed using the support vector machine (SVM) was able to provide accuracy, sensitivity, and specificity of 88.79, 89.58 and 88.23%, respectively for lung cancer, and 78.70, 72.50 and 82.35%, respectively for COPD. CONCLUSIONS: The sensor array system developed with TGS gas sensors was non-invasive, low cost, and gave a rapid response. It has been demonstrated that the VOC profiles of patients with pulmonary diseases and healthy controls are different, hence, the e-nose system can be used as a potential diagnostic device for patients with lung diseases"
Keywords:Breath Tests Electronic Nose Exhalation Humans *Lung Neoplasms/diagnosis *Volatile Organic Compounds;
Notes:"MedlineBinson, V A Subramoniam, M eng Poland 2021/12/01 Acta Bioeng Biomech. 2021; 23(1):35-44"

 
Back to top
 
Citation: El-Sayed AM 2024. The Pherobase: Database of Pheromones and Semiochemicals. <http://www.pherobase.com>.
© 2003-2024 The Pherobase - Extensive Database of Pheromones and Semiochemicals. Ashraf M. El-Sayed.
Page created on 22-09-2024